In our study, we confirmed Nrf2 as a potential target of PXA, and Nrf2 overexpression markedly reversed the inhibitory effect on CRC cell survival and the occurrence of ferroptosis induced by the combination of PXA and CDDP. The gene discussed is NFE2L2; the disease is colorectal carcinoma.